Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 107, Issue 6, 2011, Pages 857-862

  Erkol, Ayhan ^a   Pala, Selcuk ^b   Krma, Cevat ^b   Oduncu, Vecih ^b   Dündar, Cihan ^b   Izgi, Akn ^b   Tigen, Kürsat ^b   Gibson, C Michael ^c  

^a Kocaeli Derince Education and Research Hospital   (Turkey)

^b KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOPROTEGERIN; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HOSPITAL ADMISSION; HUMAN; LOADING DRUG DOSE; MALE; MICROANGIOPATHY; MICROCIRCULATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; VASCULAR RESISTANCE;

ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; OSTEOPROTEGERIN; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 79952316292     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.10.071     Document Type: Article

References (28)

1. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J Am Coll Cardiol 54 2009 281 292
2. W.F. Fearon, M. Shah, M. Ng, T. Brinton, A. Wilson, J.A. Tremmel, I. Schnittger, D.P. Lee, R.H. Vagelos, P.J. Fitzgerald, P.G. Yock, and A.C. Yeung Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 51 2008 560 565
3. L. Galiuto, B. Garramone, A. Scar, A.G. Rebuzzi, F. Crea, G. La Torre, S. Funaro, M. Madonna, F. Fedele, L. Agati AMICI Investigators The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study J Am Coll Cardiol 51 2008 552 559
4. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342 (Pubitemid 40852708)
5. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Lüthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, and W.J. Boyle Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319 (Pubitemid 27199902)
6. S. Jono, Y. Ikari, A. Shioi, K. Mori, T. Miki, K. Hara, and Y. Nishizawa Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 2002 1192 1194 (Pubitemid 34988634)
7. W.J. Sandberg, A. Yndestad, E. Øie, C. Smith, T. Ueland, O. Ovchinnikova, A.K. Robertson, F. Müller, A.G. Semb, H. Scholz, A.K. Andreassen, L. Gullestad, J.K. Dams, S.S. Frøland, G.K. Hansson, B. Halvorsen, and P. Aukrust Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization Arterioscler Thromb Vasc Biol 26 2006 857 863 (Pubitemid 43732163)
8. A. Crisafulli, A. Micari, D. Altavilla, F. Saporito, A. Sardella, M. Passaniti, S. Raffa, G. D'anneo, F. Luc, C. Mioni, F. Arrigo, and F. Squadrito Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction Clin Sci (Lond) 109 2005 389 395 (Pubitemid 41445246)
9. T. Ueland, R. Jemtland, K. Godang, J. Kjekshus, A. Hognestad, T. Omland, I.B. Squire, L. Gullestad, J. Bollerslev, K. Dickstein, and P. Aukrust Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction J Am Coll Cardiol 44 2004 1970 1976 (Pubitemid 39473280)
10. T. Omland, T. Ueland, A.M. Jansson, A. Persson, T. Karlsson, C. Smith, J. Herlitz, P. Aukrust, M. Hartford, and K. Caidahl Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes J Am Coll Cardiol 51 2008 627 633 (Pubitemid 351193104)
11. P. Secchiero, F. Corallini, A.P. Beltrami, C. Ceconi, V. Bonasia, A. Di Chiara, R. Ferrari, and G. Zauli An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction Atherosclerosis 210 2010 274 277
12. C.M. Gibson, S.A. Murphy, M.J. Rizzo, K.A. Ryan, S.J. Marble, C.H. McCabe, C.P. Cannon, F. Van de Werf, and E. Braunwald The relationship between the TIMI frame count and clinical outcomes after thrombolytic administration Circulation 99 1999 1945 1950 (Pubitemid 29183889)
13. A.W.J. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306 (Pubitemid 28280383)
14. J.S. Gottdiener, J. Bednarz, R. Devereux, J. Gardin, A. Klein, W.J. Manning, A. Morehead, D. Kitzman, J. Oh, M. Quinones, N.B. Schiller, J.H. Stein, and N.J. Weissman American Society of Echocardiography recommendations for use of echocardiography in clinical trials J Am Soc Echocardiogr 17 2004 1086 1119
15. A. Prasad, G.W. Stone, D.R. Holmes, and B. Gersh Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion Circulation 120 2009 2105 2112
16. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
17. S.C. Bekkers, S.K. Yazdani, R. Virmani, and J. Waltenberger MVO: underlying pathophysiology and clinical diagnosis J Am Coll Cardiol 55 2010 1649 1660
18. G. Ambrosio, and I. Tritto Reperfusion injury: experimental evidence and clinical implications Am Heart J 138 1999 69 75
19. S.H. Mangan, A.V. Campenhout, C. Rush, and J. Golledege Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumour necrosis factor-a associated with induction of angiopoietin-2 Cardiovasc Res 76 2007 494 505 (Pubitemid 350007458)
20. G. Zauli, F. Corallini, F. Bossi, F. Fischetti, P. Durigutto, C. Celeghini, F. Tedesco, and P. Secchiero Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo Blood 110 2007 536 543 (Pubitemid 47105391)
21. R. McGeoch, S. Watkins, C. Berry, T. Steedman, A. Davie, J. Byrne, S. Hillis, M. Lindsay, S. Robb, H. Dargie, and K. Oldroyd The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction JACC Cardiovasc Interv 3 2010 715 722
22. H.S. Lim, M.H. Yoon, S.J. Tahk, H.M. Yang, B.J. Choi, S.Y. Choi, S.S. Sheen, G.S. Hwang, S.J. Kang, and J.H. Shin Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction Eur Heart J 30 2009 2854 2860
23. W. Aarnoudse, W.F. Fearon, G. Manoharan, M. Geven, F. van de Vosse, M. Rutten, B. De Bruyne, and N.H. Pijls Epicardial stenosis severity does not affect minimal microcirculatory resistance Circulation 110 2004 2137 2142 (Pubitemid 39372491)
24. K.C. Wu, R.J. Kim, D.A. Bluemke, C.E. Rochitte, E.A. Zerhouni, L.C. Becker, and J.A. Lima Quantification and time course of MVO by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion J Am Coll Cardiol 32 1998 1756 1764 (Pubitemid 28560223)
25. L. Galiuto, F.A. Gabrielli, A. Lombardo, G. La Torre, A. Scar, A.G. Rebuzzi, and F. Crea Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodelling Heart 93 2007 565 571 (Pubitemid 46707107)
26. M. Grabowski, K.J. Filipiak, G. Karpinski, D. Wretowski, A. Rdzanek, Z. Huczek, G.J. Horszczaruk, J. Kochman, R. Rudowski, and G. Opolski Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty Am Heart J 148 2004 655 662 (Pubitemid 39349386)
27. Y.H. Jeong, W.J. Kim, D.W. Park, B.R. Choi, S.W. Lee, Y.H. Kim, C.W. Lee, M.K. Hong, J.J. Kim, S.W. Park, and S.J. Park Serum B-type natriuretic peptide on admission can predict the "no-reflow" phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction Int J Cardiol 141 2010 175 181
28. S.M. Venuraju, A. Yerramasu, R. Corder, and A. Lahiri Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity J Am Coll Cardiol 55 2010 2049 2061